Gangqi Sun

Doxorubicin-liposome combined with clodronate-liposome inhibits hepatocellular carcinoma through the depletion of macrophages and tumor cells.

Zhi-peng Han, Dandan Sheng, Xue Yang, 2022, International journal of pharmaceutics.

Lipopolysaccharide modification enhances the inhibitory effect of clodronate liposomes on hepatic fibrosis by depletion of macrophages and hepatic stellate cells.

Chen Zong, Xiao-juan Hou, Li Zhang, 2024, Chemico-biological interactions.